Medicinal cannabis medicines can be prescribed for patients as a result of federal legislative changes which came into effect in November 2016.

Many prescribers and health professionals know little about the clinical application of medicinal cannabis for a number of reasons, including the scarcity of contemporary research in this area. Following systematic reviews by the National Drug and Alcohol Research Centre and work across several Australian Universities to assess the clinical evidence for the use, the Therapeutic Goods Administration (TGA) has published guidance documents to educate and inform health professionals who are interested in medicinal cannabis as a treatment option for their patients.  These cover five particular clinical areas; specifically multiple sclerosis, chronic non-cancer pain, chemotherapy-induced nausea and vomiting in cancer, epilepsy and palliative care. There is also an overarching summary document for both health professionals and patients providing information about side effects of medicinal cannabis treatment and general cautions.

SA Health continues to aid awareness and education for health professionals and consumers through the provision of up-to-date and balanced information. You can find out more about prescribing medicinal cannabis in South Australia, and links to other resources such as fact sheets here.